FindTrial
Sign In

Mechanism of vitamin D in vagina tissue for atrophic vaginitis treatment

Mechanism of vitamin D of Rho A and ERM expression in premenopause and postmenopause vaginal tissues.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001559
Enrollment
80
Registered
2015-07-07
Start date
2012-07-17
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Research Foundation
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients who were undertaken hysterectomy, anterior repair, posterior repair, LeFort repair in the Soonchunhyang university hospital.

Exclusion criteria

Exclusion criteria: cancer tissue on biopsy, case talking by a medical illness or other diseases, not accept and check of theprogress normally, Recently, women have continued to take a vitamin D preparations within three months.

Design outcomes

Primary

MeasureTime frame
observation the expression of Rho A (Ras homolog gene family, member A) and ERM (Ezrin-Radixin-Moesin) by immunohistochemistry—

Secondary

MeasureTime frame
observation the expression rate of Rho A (Ras homolog gene family, member A) and ERM (Ezrin-Radixin-Moesin) by western blot—

Countries

Korea, Republic of

Contacts

Public ContactTae kim

Soon Chun Hyang University Hospital Bucheon

heeobgy@naver.com+82-32-621-5380

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026